Product Images Sumatriptan Succinate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Sumatriptan Succinate NDC 71205-251 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chemical-structure - chemical structure
71205-251-09 - sumatriptan carton 50mg
This is a medication package for Sumatriptan Succinate 50mg tablets by Proficient Rx LP. The tablets are white, triangular-shaped, film-coated, and each contain sumatriptan succinate USP equivalent to 50mg of sumatriptan. The tablets are marked with "S" on one side and "50" on the other. The package comes with 9 tablets with a lot number and expiration date. The medication should only be used with a prescription and must be kept out of children's reach at a temperature between 20°C and 25°C (68°F and 77°F).*
Sumatriptan-figure-1 - sumatriptan figure 1
This is a figure showing the estimated probability of responding to oral sumatriptan within 4 hours of treatment for a headache. The data is based on pooled information from three clinical controlled trials that show the efficacy of the medication. The probabilities are shown on a graph over time, with different dosages of sumatriptan displayed. The graph is a Kaplan-Meier plot that is censored at 240 minutes for patients who did not achieve a response or had to take rescue medication.*
Sumatriptan-figure-2 - sumatriptan figure 2
This is a figure and a table showing the estimated probability of patients taking a second dose of Sumatriptan Succinate Tablets or other medication to treat migraine over the 24 hours following the initial dose of study treatment in pooled trials 1, 2, and 3. The Kaplan-Meier plot is based on data obtained in the 3 clinical controlled trials which provide evidence of efficacy with patients not using additional treatments censored to 24 hours. The plot also includes patients who had no response to the initial dose. No remedication was allowed within 2 hours postdose.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
